These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 32805151)

  • 21. Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study.
    Dressler D; Rychlik R; Kreimendahl F; Schnur N; Lambert-Baumann J
    BMJ Open; 2015 Dec; 5(12):e009358. PubMed ID: 26719317
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Botulinum Toxin Type A Improves Function According to Goal Attainment in Adults with Poststroke Lower Limb Spasticity in Real Life Practice.
    López de Munain L; Valls-Solé J; Garcia Pascual I; Maisonobe P;
    Eur Neurol; 2019; 82(1-3):1-8. PubMed ID: 31726452
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should rehabilitation goals reflect all aspects of functioning in relation to a biopsychosocial ICF perspective?
    Riis-Djernæs LM; Jensen CM; Madsen E; Maribo T
    Disabil Rehabil; 2021 Jun; 43(12):1669-1674. PubMed ID: 31589085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Discontinuation of botulinum neurotoxin type-A treatment during COVID-19 pandemic: an Italian survey in post stroke and traumatic brain injury patients living with spasticity.
    Santamato A; Facciorusso S; Spina S; Cinone N; Avvantaggiato C; Santoro L; Ciritella C; Smania N; Picelli A; Gasperini G; Molteni F; Baricich A; Fiore P
    Eur J Phys Rehabil Med; 2021 Jun; 57(3):424-433. PubMed ID: 33263248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Factors influencing goal attainment in patients with post-stroke upper limb spasticity following treatment with botulinum toxin A in real-life clinical practice: sub-analyses from the Upper Limb International Spasticity (ULIS)-II Study.
    Fheodoroff K; Ashford S; Jacinto J; Maisonobe P; Balcaitiene J; Turner-Stokes L
    Toxins (Basel); 2015 Apr; 7(4):1192-205. PubMed ID: 25856546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inter-rater agreement when linking stroke interventions to the extended international classification of functioning, disability and health core set for stroke.
    Evans M; Sykes C; Hocking C; Siegert R; Garratt N
    Disabil Rehabil; 2022 Dec; 44(25):8022-8028. PubMed ID: 34870548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of the neuro-orthopedic surgery for spastic equinovarus foot after stroke: a prospective longitudinal study based on a goal-centered approach.
    Deltombe T; Gilliaux M; Peret F; Leeuwerck M; Wautier D; Hanson P; Gustin T
    Eur J Phys Rehabil Med; 2018 Dec; 54(6):853-859. PubMed ID: 29904043
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ICF linking of patient-reported therapy goals for children with acquired upper extremity impairment.
    Dorich JM; Cornwall R; Uhl T
    J Hand Ther; 2023; 36(1):74-84. PubMed ID: 34247881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burden of treatment in the light of the international classification of functioning, disability and health: a "best fit" framework synthesis.
    Gonçalves AV; Jácome CI; Demain SH; Hunt KJ; Marques AS
    Disabil Rehabil; 2017 Jun; 39(13):1253-1261. PubMed ID: 27374769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Goal-setting in multidisciplinary team care for patients with rheumatoid arthritis: an international multi-center evaluation of the contents using the International Classification of Functioning, Disability and Health as a reference.
    Meesters J; Hagel S; Klokkerud M; Stovgaard I; Bremander A; Grotle M; Hørslev-Petersen K; Petersson IF; Hagen KB; Pont W; Vlieland TV
    J Rehabil Med; 2013 Sep; 45(9):888-99. PubMed ID: 23974511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial.
    Turner-Stokes L; Baguley IJ; De Graaff S; Katrak P; Davies L; McCrory P; Hughes A
    J Rehabil Med; 2010 Jan; 42(1):81-9. PubMed ID: 20111849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward the International Classification of Functioning, Disability and Health (ICF) Rehabilitation Set: A Minimal Generic Set of Domains for Rehabilitation as a Health Strategy.
    Prodinger B; Cieza A; Oberhauser C; Bickenbach J; Üstün TB; Chatterji S; Stucki G
    Arch Phys Med Rehabil; 2016 Jun; 97(6):875-84. PubMed ID: 26827829
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Construction of an ICF core set and ICF-based questionnaire assessing activities and participation in patients with systemic sclerosis.
    Papelard A; Daste C; Alami S; Sanchez K; Roren A; Segretin F; Lefèvre-Colau MM; Rannou F; Mouthon L; Poiraudeau S; Nguyen C
    Rheumatology (Oxford); 2019 Dec; 58(12):2260-2272. PubMed ID: 31219594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does botulinum toxin treatment improve upper limb active function?
    Levy J; Molteni F; Cannaviello G; Lansaman T; Roche N; Bensmail D
    Ann Phys Rehabil Med; 2019 Jul; 62(4):234-240. PubMed ID: 29960017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Refinements of the ICF Linking Rules to strengthen their potential for establishing comparability of health information.
    Cieza A; Fayed N; Bickenbach J; Prodinger B
    Disabil Rehabil; 2019 Mar; 41(5):574-583. PubMed ID: 26984720
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a modular ICF-based core set for the German substance use disorders treatment.
    Spies M; Meyer-Steinkamp R; Stracke R; Buchholz A
    Disabil Rehabil; 2022 Apr; 44(8):1234-1242. PubMed ID: 32723115
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Longitudinal goal attainment with integrated upper limb spasticity management including repeat injections of botulinum toxin A: Findings from the prospective, observational Upper Limb International Spasticity (ULIS-III) cohort study.
    Turner-Stokes L; Jacinto J; Fheodoroff K; Brashear A; Maisonobe P; Lysandropoulos A; Ashford S;
    J Rehabil Med; 2021 Feb; 53(2):jrm00157. PubMed ID: 33616192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IncobotulinumtoxinA Treatment in Upper-Limb Poststroke Spasticity in the Open-Label Extension Period of PURE: Efficacy in Passive Function, Caregiver Burden, and Quality of Life.
    Marciniak C; Munin MC; Brashear A; Rubin BS; Patel AT; Slawek J; Hanschmann A; Hiersemenzel R; Elovic EP
    PM R; 2020 May; 12(5):491-499. PubMed ID: 31647185
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interdisciplinary spasticity management clinic outcomes using the Goal Attainment Scale: A retrospective chart review.
    Hanlan A; Mills P; Lipson R; Finlayson H
    J Rehabil Med; 2017 May; 49(5):423-430. PubMed ID: 28480944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intervention Goals for Preschoolers With Language Difficulties and Disorders: A Scoping Review Using the International Classification of Functioning, Disability and Health Framework.
    Kwok E; Cermak CA; Hatherly K; Cunningham BJ
    Am J Speech Lang Pathol; 2022 May; 31(3):1-70. PubMed ID: 35302873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.